JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2025-04-27 享耳来自北京

偏重的研究方向：临床研究
经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review

2 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2024-06-21 小胖子罗军来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：光动力
经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice

122 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2022-10-30 ms4000000613289763

请问投稿10天状态直接变成Decession in process，是要被拒稿了吗

242 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2024-04-30 1de0ba61m50(暂无匿称) 来自青海省

皮肤病个案有推荐的杂志吗

97 0

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2024-04-30 1de0ba61m50(暂无匿称) 来自青海省

皮肤病个案有推荐的杂志吗

88 0

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2023-12-10 ms9000001314913623 来自山西省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投稿后建议修改为research letter，各位同仁怎么看

133 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2022-11-22 ms9000001195231403

请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～

227 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2022-05-31 中中y

提交4,5天了，还是submission to journal，有人知道这是啥情况嘛

268 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2022-11-09 ms1000000155957628

请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶

227 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262475, encodeId=c79922624e5ed, content=偏重的研究方向：临床研究 经验分享：投了一个，占个坑。整形的article 投稿了 JAAD 看看啥时候被拒 4.16submission 4.23under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1225508724, createdName=享耳, createdTime=Sun Apr 27 13:30:34 CST 2025, time=2025-04-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210958, encodeId=0a842210958a2, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：我们课题组已经发了很多篇JAAD，这个杂志不收基础研究，如果临床研究他们觉得质量不够，会让改成letter，主编很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Fri Jun 21 10:12:49 CST 2024, time=2024-06-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2097457, encodeId=0b31209e4572c, content=请问投稿10天状态直接变成Decession in process，是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d86510854, createdName=ms4000000613289763, createdTime=Sun Oct 30 13:09:02 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201301, encodeId=49d22201301ef, content=皮肤病个案有推荐的杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:44:28 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2201300, encodeId=a6bf22013008f, content=皮肤病个案有推荐的杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1371669922, createdName=1de0ba61m50(暂无匿称), createdTime=Tue Apr 30 21:43:22 CST 2024, time=2024-04-30, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174052, encodeId=fd9d21e40527a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后建议修改为research letter，各位同仁怎么看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Sun Dec 10 15:19:28 CST 2023, time=2023-12-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2101894, encodeId=ee87210189495, content=请问提交了文章以后，每个作者都必须根据邮件里面的网址进行确认之后杂志社才会进一步处理吗？谢谢各位～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0ad5474507, createdName=ms9000001195231403, createdTime=Tue Nov 22 09:06:05 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223551, encodeId=9ea81223551b8, content=提交4,5天了，还是submission to journal，有人知道这是啥情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=中中y, createdTime=Tue May 31 10:24:39 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099302, encodeId=969b209930259, content=请问有没有投过基础研究的呀，我找了好久发现国人投到JAAD基本都是临床研究为主诶, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Wed Nov 09 01:39:10 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099288, encodeId=803f209928820, content=请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10425631077, createdName=ms1000000155957628, createdTime=Tue Nov 08 23:54:39 CST 2022, time=2022-11-08, status=1, ipAttribution=)]

2022-11-08 ms1000000155957628

请问有投过JAAD的小伙伴吗，我想问一下这个要怎么添加共同一作和共通讯啊，填信息那一栏都没有相关选项

219 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务